Rosalind A. Eeles

Active 1991–2025

250
Papers
59,881
Citations
120
h-index
245
i10-index

Citations

Citations per year for Rosalind A. Eeles1951: 1 citations1991: 1 citations1993: 8 citations1994: 23 citations1995: 40 citations1996: 62 citations1997: 95 citations1998: 96 citations1999: 130 citations2000: 135 citations2001: 129 citations2002: 131 citations2003: 159 citations2004: 204 citations2005: 180 citations2006: 227 citations2007: 255 citations2008: 245 citations2009: 284 citations2010: 378 citations2011: 322 citations2012: 268 citations2013: 311 citations2014: 350 citations2015: 431 citations2016: 591 citations2017: 631 citations2018: 741 citations2019: 2,029 citations2020: 2,206 citations2021: 2,096 citations2022: 1,512 citations2023: 898 citations2024: 1,651 citations2025: 705 citations2026: 17 citations1952–1990: no citations, so these years are not shown1992: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 6,288 citing papers, 22.7% of this breakdownUnited Kingdom: 2,682 citing papers, 9.7% of this breakdownChina: 1,594 citing papers, 5.8% of this breakdownCanada: 1,383 citing papers, 5% of this breakdownGermany: 1,372 citing papers, 4.9% of this breakdownItaly: 1,158 citing papers, 4.2% of this breakdownAustralia: 1,136 citing papers, 4.1% of this breakdownFrance: 1,037 citing papers, 3.7% of this breakdownNetherlands: 960 citing papers, 3.5% of this breakdownSpain: 806 citing papers, 2.9% of this breakdownSweden: 681 citing papers, 2.5% of this breakdownJapan: 519 citing papers, 1.9% of this breakdown
0%22.7%Other 29.1%

Fields

  • Medicine47.3%
  • Biochemistry, Genetics and Molecular Biology46.1%
  • Computer Science1.1%
  • Agricultural and Biological Sciences1.1%
  • Immunology and Microbiology1%
  • Neuroscience0.7%
  • Other2.7%

Topics

  • BRCA gene mutations in cancer6.9%
  • Prostate Cancer Treatment and Research5.7%
  • Cancer Genomics and Diagnostics4.1%
  • Prostate Cancer Diagnosis and Treatment3.7%
  • DNA Repair Mechanisms2.9%
  • PARP inhibition in cancer therapy2.7%
  • Other74%

Coauthors

All papers

Open in search
  1. REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rosalind A. Eeles, Zsofia Kote‐Jarai, Carlos D. Bustamante, Daniel J. Schaid, Trevor Hastie, Elaine A. Ostrander, Joan E. Bailey‐Wilson, Predrag Radivojac, Stephen N. Thibodeau, Alice S. Whittemore, Weiva Sieh - The American Journal of Human Genetics 2016 cited by 2,986

  2. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jean‐Pierre Fricker, Laurence Faivre, Pascaline Berthet, Maartje J. Hooning, Lizet E. van der Kolk, Carolien M. Kets, Muriel A. Adank, Esther M. John, Wendy K. Chung, Irene L. Andrulis, Melissa C. Southey, Mary B. Daly, Saundra S. Buys, Ana Osório, Christoph Engel, Karin Kast, Rita K. Schmutzler, Trinidad Caldés, Anna Jakubowska, Jacques Simard, Michael Friedländer, Sue‐Anne McLachlan, Eva Macháčková, Lenka Foretová, Yen Y. Tan, Christian F. Singer, Edith Oláh, Anne‐Marie Gerdes, Brita Arver, Håkan Olsson - JAMA 2017 cited by 2,863

  3. The Lancet Commission on prostate cancer: planning for the surge in cases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anwar R. Padhani, Charles Parker, Hannah Rush, Mark Sculpher, Howard R. Soule, Matthew R. Sydes, Derya Tilki, Nina Tunariu, Paul Villanti, Liping Xie - The Lancet 2024 cited by 643

  4. Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Liying Zhang, Ahmet Zehir, Joseph Vijai, Howard I. Scher, Charles L. Sawyers, Nikolaus Schultz, Philip W. Kantoff, David B. Solit, Mark E. Robson, Eliezer M. Van Allen, Kenneth Offit, Johann S. de Bono, Peter S. Nelson - New England Journal of Medicine 2016 cited by 1,663

  5. DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bernardette Ebbs, Gemma Fowler, Desamparados Roda, Wei Yuan, Yi‐Mi Wu, Xuhong Cao, Rachel Brough, Helen N. Pemberton, Roger A’Hern, Amanda Swain, Lakshmi P. Kunju, Rosalind A. Eeles, Gerhardt Attard, Christopher J. Lord, Alan Ashworth, Mark A. Rubin, Karen E. Knudsen, Felix Y. Feng, Arul M. Chinnaiyan, Emma Hall, Johann S. de Bono - New England Journal of Medicine 2015 cited by 2,187

  6. The evolutionary history of lethal metastatic prostate cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , G. Steven Bova - Nature 2015 cited by 1,455

  7. Germline BRCA Mutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lucy Side, Jacqueline Eason, Alex Murray, Antonis C. Antoniou, Douglas F. Easton, Zsofia Kote‐Jarai, Rosalind A. Eeles - Journal of Clinical Oncology 2013 cited by 824

  8. Prostate cancer

    Authors: , , , , , , , - The Lancet 2015 cited by 917

  9. Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jack A. Taylor, D Neil Hayes, David Malkin, ICGC Breast Cancer Group, ICGC Chronic Myeloid Disorders Group, ICGC Prostate Cancer Group, Christopher S. Foster, Anne Y. Warren, Hayley C. Whitaker, Daniel S. Brewer, Rosalind A. Eeles, Colin Cooper, David E. Neal, Tapio Visakorpi, William B. Isaacs, G. Steven Bova, Adrienne M. Flanagan, P. Andrew Futreal, Andy G. Lynch, Patrick F. Chinnery, Ultan McDermott, Michael R. Stratton, Peter J. Campbell - eLife 2014 cited by 500

  10. Identification of the breast cancer susceptibility gene BRCA2

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cees J. Cornelisse, Henry T. Lynch, Steven A. Narod, Gilbert Lenoir, V Egilsson, Rosa Bjork Barkadottir, Douglas F. Easton, David Bentley, P. Andrew Futreal, Alan Ashworth, Michael R. Stratton - Nature 1995 cited by 3,663

  11. Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2018 cited by 495

  12. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Laura Mudie, Claire Hardy, Sancha Martin, Stuart McLaren, Sarah O’Meara, Elizabeth Anderson, Mark Maddison, Stephen J. Gamble, ICGC Breast Cancer Group, ICGC Bone Cancer Group, ICGC Prostate Cancer Group, Christopher S. Foster, Anne Y. Warren, Hayley C. Whitaker, Daniel Brewer, Rosalind A. Eeles, Colin Cooper, David E. Neal, Andy G. Lynch, Tapio Visakorpi, William B. Isaacs, Laura van’t Veer, Carlos Caldas, Christine Desmedt, Christos Sotiriou, Samuel Aparício, John A. Foekens, Jórunn E. Eyfjörd, Sunil R. Lakhani, Gilles Thomas, Ola Myklebost, Paul N. Span, Anne‐Lise Børresen‐Dale, Andrea L. Richardson, Marc J. van de Vijver, Anne Vincent‐Salomon, Gert G. Van den Eynden, Adrienne M. Flanagan, P. Andrew Futreal, Sam M. Janes, G. Steven Bova, Michael R. Stratton, Ultan McDermott, Peter J. Campbell - Science 2014 cited by 443

  13. Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Noel W. Clarke, Gedske Daugaard, Maria De Santis, Ignacio Durán, Rosalind A. Eeles, Eleni Efstathiou, Jason A. Efstathiou, Onyeanunam Ngozi Ekeke, Christopher P. Evans, Stefano Fanti, Felix Y. Feng, Valérie Fonteyne, Nicola Fossati, Mark Frydenberg, Daniel J. George, Martin Gleave, Gwénaëlle Gravis, Susan Halabi, Daniel Heinrich, Ken Herrmann, Celestia S. Higano, Michael S. Hofman, Lisa G. Horvath, Maha Hussain, Barbara Alicja Jereczek‐Fossa, Robert J. Jones, Ravindran Kanesvaran, Pirkko‐Liisa Kellokumpu‐Lehtinen, Raja B. Khauli, Laurence Klotz, Gero Kramer, Raya Leibowitz‐Amit, Christopher J. Logothetis, Brandon A. Mahal, Fernando Cotait Maluf, Joaquı́n Mateo, David Matheson, Niven Mehra, Axel S. Merseburger, Alicia K. Morgans, Michael J. Morris, Hind M’rabti, Deborah Mukherji, Declan G. Murphy, Vedang Murthy, Paul L. Nguyen, William Oh, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Carmel Pezaro, Darren M.C. Poon, Colin C. Pritchard, Danny Rabah, Dana E. Rathkopf, Robert E. Reiter, Mark A. Rubin, Charles J. Ryan, Fred Saad, Juan Pablo Sade, Oliver A. Sartor, Howard I. Scher, Nima Sharifi, Iwona Skoneczna, Howard R. Soule, Daniel E. Spratt, Sandy Srinivas, Cora N. Sternberg, Thomas Steuber, Hiroyoshi Suzuki and 18 more - European Urology 2022 cited by 118

  14. Spatial genomic heterogeneity within localized, multifocal prostate cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stephenie D. Prokopec, Jenna Sykes, Alan Dal Pra, Alejandro Berlín, Andrew Brown, Michelle Chan‐Seng‐Yue, Fouad Yousif, Robert E. Denroche, Lauren C. Chong, Gregory M. Chen, Esther Jung, Clement Fung, Maud H. W. Starmans, Hanbo Chen, Shaylan K. Govind, James R. Hawley, Alister D’Costa, Melania Pintilie, Daryl Waggott, Faraz Hach, Philippe Lambin, Lakshmi Muthuswamy, Colin Cooper, Rosalind A. Eeles, David E. Neal, Bernard Têtu, Cenk Sahinalp, Lincoln Stein, Neil Fleshner, Sohrab P. Shah, Colin C. Collins, Thomas J. Hudson, John D. McPherson, Theodorus van der Kwast, Robert G. Bristow - Nature Genetics 2015 cited by 489

  15. Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Julian Barwell, Emma McCann, Alex Murray, Antonis C. Antoniou, Douglas F. Easton, on behalf of EMBRACE - JNCI Journal of the National Cancer Institute 2013 cited by 939

  16. Prostate Cancer Risks for Male BRCA1 and BRCA2 Mutation Carriers: A Prospective Cohort Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Douglas F. Easton, Antonis C. Antoniou - European Urology 2019 cited by 246

  17. Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Deborah J. Thompson, Tracy A. O’Mara, Brian M. Wolpin, Laufey T. Ámundadóttir, Rachael Z. Stolzenberg‐Solomon, Antonia Trichopoulou, N. Charlotte Onland‐Moret, Eiliv Lund, Eric J. Duell, Federico Canzian, Gianluca Severi, Kim Overvad, Marc J. Gunter, ­Rosario ­Tumino, Ulrika Svenson, André van Rij, Annette F. Baas, Matthew J. Bown, Nilesh J. Samani, Femke N.G. van t’Hof, Gerard Tromp, Gregory T. Jones, Helena Kuivaniemi, James R. Elmore, Mattias Johansson, James McKay, Ghislaine Scélo, Robert Carreras‐Torres, Valérie Gaborieau, Paul Brennan, Paige M. Bracci, Rachel Ε. Neale, Sara H. Olson, Steven Gallinger, Donghui Li, Gloria M. Petersen, Harvey A. Risch, Alison P. Klein, Jiali Han, Christian C. Abnet, Neal D. Freedman, Philip R. Taylor, John M. Maris, Katja K.H. Aben, Lambertus A. Kiemeney, Sita H. Vermeulen, John K. Wiencke, Kyle M. Walsh, Margaret Wrensch, Terri Rice, Clare Turnbull, Kevin Litchfield, Lavinia Paternoster, Marie Standl, Gonçalo R. Abecasis, John Paul SanGiovanni, Yong Li, Vladan Mijatovic, Yadav Sapkota, Siew‐Kee Low, Krina T. Zondervan, Grant W. Montgomery, Dale R. Nyholt, David A. van Heel, Karen A. Hunt, Dan E. Arking, Foram N. Ashar, Nona Sotoodehnia, Daniel Woo, Jonathan Rosand and 98 more - JAMA Oncology 2017 cited by 529

  18. Association of Type and Location ofBRCA1andBRCA2Mutations With Risk of Breast and Ovarian Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kunle Odunsi, Simon A. Gayther, Susan M. Domchek, Banu Arun, Karen H. Lu, Gillian Mitchell, Beth Y. Karlan, Christine Walsh, Jenny Lester, Andrew K. Godwin, Harsh B. Pathak, Eric A. Ross, Mary B. Daly, Alice S. Whittemore, Esther M. John, Alexander Miron, Mary Beth Terry, Wendy K. Chung, David E. Goldgar, Saundra S. Buys, Ramūnas Janavičius, Laima Tihomirova, Nadine Tung, Cecilia M. Dorfling, Elizabeth J. van Rensburg, Linda Steele, Susan L. Neuhausen, Yuan Chun Ding, Bent Ejlertsen, Anne‐Marie Gerdes, Thomas van Overeem Hansen, Teresa Ramón y Cajal, Ana Osório, Javier Benı́tez, Javier Godino, María‐Isabel Tejada, M. Durán, Jeffrey N. Weitzel, Kristie Bobolis, Sharon Sand, Annette Campbell Fontaine, Antonella Savarese, Barbara Pasini, Bernard Peissel, Bernardo Bonanni, Daniela Zaffaroni, Francesca Vignolo-Lutati, Giulietta Scuvera, Giuseppe Giannini, Loris Bernard, Maurizio Genuardi, Paolo Radice, Riccardo Dolcetti, Siranoush Manoukian, Valeria Pensotti, Viviana Gismondi, Drakoulis Yannoukakos, Florentia Fostira, Judy E. Garber, Diana Torres, Muhammad Usman Rashid, Ute Hamann, Susan Peock, Debra Frost, Radka Platte, D. Gareth Evans, Rosalind A. Eeles, Rosemarie Davidson, Diana Eccles, Trevor Cole and 158 more - JAMA 2015 cited by 509

  19. Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gero Kramer, Chris Logothetis, Fernando Cotait Maluf, Alicia K. Morgans, Michael J. Morris, Nicolas Mottet, Vedang Murthy, William Oh, Piet Ost, Anwar R. Padhani, Chris Parker, Colin C. Pritchard, Mack Roach, Mark A. Rubin, Charles J. Ryan, Fred Saad, Oliver Sartor, Howard I. Scher, Avishay Sella, Neal D. Shore, Matthew R. Smith, Howard R. Soule, Cora N. Sternberg, Hiroyoshi Suzuki, Christopher J. Sweeney, Matthew R. Sydes, Ian F. Tannock, Bertrand Tombal, R. Valdagni, Thomas Wiegel, Aurelius Omlin - European Urology 2017 cited by 643

  20. Prevention and early detection of prostate cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2014 cited by 492

  21. Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - European Urology 2014 cited by 370

  22. Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Paul C. Boutros, Michael Fraser, Susanna L. Cooke, Keiran Raine, David Jones, Andrew Menzies, Lucy Stebbings, Jon Hinton, Jon W. Teague, Stuart McLaren, Laura Mudie, Claire Hardy, Elizabeth Anderson, Olivia Joseph, Victoria Goody, Ben Robinson, Mark Maddison, Stephen J. Gamble, Christopher Greenman, Daniel M. Berney, Steven Hazell, Naomi Livni, Cyril Fisher, Christopher Ogden, Pardeep Kumar, Alan Thompson, Christopher Woodhouse, David M. Nicol, Erik Mayer, Tim Dudderidge, Nimish Shah, Vincent J. Gnanapragasam, Thierry Voet, Peter J. Campbell, P. Andrew Futreal, Douglas Easton, Anne Y. Warren, Christopher S. Foster, Michael R. Stratton, Hayley C. Whitaker, Ultan McDermott, Daniel S. Brewer, David E. Neal - Nature Genetics 2015 cited by 457

  23. Association analyses identify 31 new risk loci for colorectal cancer susceptibility

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Roland Arnold, Elaine Johnstone, Haitao Wang, David Kerr, Rachel Kerr, Tim Maughan, Richard Kaplan, Nada Al Tassan, Kimmo Palin, Ulrika A. Hänninen, Tatiana Cajuso, Tomas Tanskanen, Johanna Kondelin, Eevi Kaasinen, Antti‐Pekka Sarin, Johan G. Eriksson, Harri Rissanen, Paul Knekt, ­Eero Pukkala, Pekka Jousilahti, Veikko Salomaa, Samuli Ripatti, Aarno Palotie, Laura Renkonen‐Sinisalo, Anna Lepistö, J. Böhm, Jukka‐Pekka Mecklin, Daniel D. Buchanan, Aung Ko Win, John L. Hopper, Mark A. Jenkins, Noralane M. Lindor, Polly A. Newcomb, Steven Gallinger, David Duggan, Graham Casey, Per Hoffmann, Markus M. Nöthen, Karl‐Heinz Jöckel, Douglas F. Easton, Paul D.P. Pharoah, Julian Peto, Federico Canzian, Anthony J. Swerdlow, Rosalind A. Eeles, Zsofia Kote‐Jarai, Kenneth Muir, Nora Pashayan, Brian E. Henderson, Christopher A. Haiman, Fredrick R. Schumacher, Ali Amin Al Olama, Sara Benlloch, Sonja I. Berndt, David V. Conti, Fredrik Wiklund, Stephen J. Chanock, Susan M. Gapstur, Victoria L. Stevens, Catherine M. Tangen, Jyotsna Batra, Judith A. Clements, Henrik Grönberg, Johanna Schleutker, Demetrius Albanes, Alicja Wolk, Catharine West, Lorelei A. Mucci, Géraldine Cancel‐Tassin, Stella Koutros and 59 more - Nature Communications 2019 cited by 272

  24. Microbiomes of Urine and the Prostate Are Linked to Human Prostate Cancer Risk Groups

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - European Urology Oncology 2022 cited by 64